Vera TherapeuticsVERA

那斯達克 · USD
31.62
-0.19
(-0.60%)
收盤 06/11 03:59 (UTC+8)
盤後 
31.63 
+0.01 
(+0.03%)
06/11 03:59 (UTC+8)

財務數據

損益表

loading
載入中...
icon
  • -
  • -
  • -
  • -
  • -
  • -
  • -
  • -
  • -
  • -
icon
  • -
  • -
  • -
  • -
  • -
  • -
  • -
  • -
  • -
  • -
  • icon
    營業收入(億)
  • icon
    季增長率(%)
單位:美元千元
年季
2026/Q1
2025/Q4
2025/Q3
2025/Q2
2025/Q1
2024/Q4
2024/Q3
2024/Q2
2024/Q1
2023/Q4
營業收入淨額
-
-
-
-
-
-
-
-
-
-
營業成本
----------
營業毛利
-
-
-
-
-
-
-
-
-
-
營業費用
125,13294,20683,93280,14157,19448,91449,80137,343-27,028
研發費用
86,01159,31056,47358,19541,27833,34740,31429,31123,20020,785
推銷及管理費用
39,12134,89627,45921,94615,91615,5679,4878,0327,9126,243
非經常性項目費用
----------
其他營業費用
----------
營業利益
-125,132
-94,206
-83,932
-80,141
-57,194
-48,914
-49,801
-37,343
-31,112
-27,028
其他收入及費用
5,9235,0145,599-7,2927,3615,1055,5484,6352,430
利息費用
1,8231,9041,9601,8741,7921,8711,9361,9131,9061,056
稅前純益
-121,032
-91,096
-80,293
-76,531
-51,694
-43,424
-46,632
-33,708
-28,383
-25,654
所得稅
-1---1---1
稅後純益
-121,032
-91,097
-80,293
-76,531
-51,694
-43,425
-46,632
-33,708
-28,383
-25,655
基本每股稅後盈餘(元)
-1.69-1.39-1.26-1.20-0.81-0.72-0.85-0.62-0.56-
稀釋每股稅後盈餘(元)
-1.69-1.39-1.26-1.20-0.81-0.72-0.86-0.61-0.56-0.58
基本平均股數(千股)
71476.0065628.0063847.0063789.0063671.0060709.0054898.0054728.0050971.00-
稀釋平均股數(千股)
71476.0065628.0063847.0063789.0063671.0060709.0054898.0054728.0050971.00-
還原基本每股稅後盈餘(元)
-1.69-1.39-1.26-1.20-0.81-0.72-0.85-0.62-0.56-
還原稀釋每股稅後盈餘(元)
-1.69-1.39-1.26-1.20-0.81-0.72-0.86-0.61-0.56-0.58
還原基本平均股數(千股)
71,47665,62863,84763,78963,67160,70954,89854,72850,971-
還原稀釋平均股數(千股)
71,47665,62863,84763,78963,67160,70954,89854,72850,971-
EBITDA(千元)
-119,273-89,529-78,812-74,538-52,127-43,347-46,896-34,389-27,946-25,765

大家都在看

HOT